Primary contact

Curisium is a healthcare technology and services company that provides scalable innovative contracting solutions with its blockchain-based platform. The company provides tailored solutions for payers, providers, and life science companies to enter into patient-centric, secure and efficient innovative contracting arrangements. The solution maintains an audit trail of all contract processes on a permissioned, immutable blockchain that each party can independently verify.
Primary contact

Funding 💰

Total $3.5M
Select investors Flare Capital Partners, New Enterprise Associates, Sanofi-Genzyme Bioventures, Green Bay Ventures, Shuttle Fund
Last update: October 26, 2018